Kamada Ltd. Reports Strong Growth and Raises Guidance
Company Announcements

Kamada Ltd. Reports Strong Growth and Raises Guidance

Kamada Ltd (IL:KMDA) has released an update.

Kamada Ltd. has reported a robust start to 2024, showcasing a 23% increase in first-quarter revenues, which amounted to $37.7 million, and a significant 96% surge in adjusted EBITDA to $7.5 million. The company’s positive performance, driven by strong U.S. sales of KEDRAB® and CYTOGAM®, has led to an upward revision of its full-year revenue and EBITDA forecasts. Kamada remains focused on growth, leveraging financial strength to explore new business opportunities and expecting double-digit growth rates to continue beyond 2024.

For further insights into IL:KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskKamada’s Strong Growth and Strategic Expansion in 2024
TheFlyKamada reports Q3 EPS 7c, consensus 7c
TheFlyKamada sees FY24 revenue $158M-$162M, consensus $160.47M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App